佐力药业 (300181.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(佐力药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 616,624,658.40755,355,592.79672,899,096.57477,493,313.53453,488,563.91515,760,738.76495,697,829.83
 营业收入(元) 616,624,658.40755,355,592.79672,899,096.57477,493,313.53453,488,563.91515,760,738.76495,697,829.83
二、营业总成本(元) 486,651,256.25606,025,636.43519,085,030.36389,320,840.66367,763,235.13420,357,009.26400,185,140.69
 营业成本(元) 251,246,214.93309,633,274.74224,227,569.29154,029,497.10148,938,047.34161,080,991.26149,293,104.83
 研发费用(元) 11,633,152.3924,606,441.9114,564,920.8121,198,595.9117,746,950.3122,227,345.3818,208,988.62
 营业税金及附加(元) 5,202,596.9411,067,863.894,948,454.138,473,180.204,481,847.187,622,094.344,397,982.44
 销售费用(元) 195,846,398.90237,735,679.17250,541,152.26179,545,209.94177,271,591.94211,951,888.96208,717,624.11
 管理费用(元) 23,990,797.9727,605,364.0525,823,312.4629,115,585.8923,165,710.6321,622,792.0322,789,483.41
 财务费用(元) -1,267,904.88-4,622,987.33-1,020,378.59-3,041,228.38-3,840,912.27-4,148,102.71-3,222,042.72
  其中:利息费用(元) 2,454,872.642,047,216.412,053,100.171,609,941.012,097,859.582,285,664.261,629,420.80
  其中:利息收入(元) 3,768,059.346,621,028.183,185,151.714,655,153.495,994,403.716,476,702.654,871,161.65
 信用减值损失(元) -3,785,744.5035,250.46-7,033,566.99-217,487.63623,185.97-96,194.98-854,871.64
三、其他经营收益
 加:投资收益(元) -465,365.81-306,327.26289,929.80189,525.58-18,398.63-114,848.71-157,004.32
  其中:对联营企业和合营企业的投资收益(元) -80,688.53348,898.67-343,062.97216,491.92-19,351.32-39,015.52-179,651.68
 资产处置收益(元) 109,794.14226,640.166,878.0038,684.11--240,442.04
 其他收益(元) 23,915,069.8328,482,444.5929,351,106.2226,133,627.5321,935,842.0320,243,819.9818,966,590.38
四、营业利润(元) 149,747,155.81177,767,964.31176,428,413.24111,296,673.59108,265,958.15115,436,505.79113,707,845.60
 加:营业外收入(元) 267,031.03228,414.2493,960.48108,081.2256,858.021.108.98
 减:营业外支出(元) -503,419.1312,119.7110,237,226.53986,655.98809,640.0593,290.69340,587.37
五、利润总额(元) 150,517,605.97177,984,258.84166,285,147.19110,418,098.83107,513,176.12115,343,216.20113,367,267.21
 减:所得税费用(元) 22,983,673.5322,242,401.7622,178,653.4312,238,875.7116,704,672.1113,021,379.0913,913,909.79
六、净利润(元) 127,533,932.44155,741,857.08144,106,493.7698,179,223.1290,808,504.01102,321,837.1199,453,357.42
(一)按经营持续性分类
  持续经营净利润(元) 127,533,932.44155,741,857.08144,106,493.7698,179,223.1290,808,504.01102,321,837.1199,453,357.42
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 125,426,028.33153,638,773.40142,415,333.7796,070,902.3089,203,600.05100,206,988.0997,454,603.35
  少数股东损益(元) 2,107,904.112,103,083.681,691,159.992,108,320.821,604,903.962,114,849.021,998,754.07
 扣除非经常性损益后的净利润(元) 122,964,581.10148,469,395.96143,633,496.5692,774,363.9687,102,516.8997,982,053.9795,751,300.20
七、每股收益
 一、基本每股收益(元) 0.180.220.200.140.130.140.14
 二、稀释每股收益(元) 0.180.220.200.140.130.140.14
八、其他综合收益(元) -1,304,785.91-23,311,191.11-8,822,828.12-37,521,097.12-27,279,330.63-46,481,876.40-48,198,899.97
 归属于母公司股东的其他综合收益(元) -1,206,979.16-21,563,784.23-8,161,468.92-34,708,515.68-25,234,472.01-42,997,594.94-44,585,910.43
 归属于少数股东的其他综合收益(元) -97,806.75-1,747,406.88-661,359.20-2,812,581.44-2,044,858.62-3,484,281.46-3,612,989.54
九、综合收益总额(元) 126,229,146.53132,430,665.97135,283,665.6460,658,126.0063,529,173.3855,839,960.7151,254,457.45
 归属于母公司所有者的综合收益总额(元) 124,219,049.17132,074,989.17134,253,864.8561,362,386.6263,969,128.0457,209,393.1552,868,692.92
 归属于少数股东的综合收益总额(元) 2,010,097.36355,676.801,029,800.79-704,260.62-439,954.66-1,369,432.44-1,614,235.47
公告日期 2024-10-282024-07-302024-04-192024-04-192023-10-232023-08-092023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院